Mark Sharobeem
NPI 1679915508 · Foot & Ankle Surgery Podiatrist · New York, NY
Enrolled with Medicare as Practitioner - Podiatry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Mark Sharobeem is a Foot & Ankle Surgery Podiatrist provider in New York, NY (NPI 1679915508).
Provider details
- NPI number
- 1679915508
- Entity type
- Individual
- Primary specialty
- Foot & Ankle Surgery PodiatristPodiatric Medicine & Surgery Service Providers
- Sex
- Male
- Sole proprietor
- No
- License
- 89599 (NY)
Specialties & taxonomies
Podiatric Medicine & Surgery Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
12 yrs in NPPES registry
- Profile completeness33% of score
100% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.
| Drug | Part D claims (2024) |
|---|---|
| Doxepin Hcl | 18 |
| Desoximetasone | 15 |
| Ketoconazole | 12 |
| Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented | 11 |
| Naftifine Hcl | 11 |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$193 across 2 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2013-07-19
- Last updated
- 2019-07-11
Frequently asked questions
- What is Mark Sharobeem's NPI number?
- Mark Sharobeem's National Provider Identifier (NPI) is 1679915508, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Mark Sharobeem's specialty?
- Mark Sharobeem is listed in the NPPES registry with a primary specialty of Foot & Ankle Surgery Podiatrist (Podiatric Medicine & Surgery Service Providers).
- Where is Mark Sharobeem located?
- Mark Sharobeem's practice location on file with NPPES is 30 Broad St Ste 401, New York, NY 10004-4110.
- What is Mark Sharobeem's phone number?
- The practice phone number listed in the NPPES registry for Mark Sharobeem is (917) 692-6408.
- Does Mark Sharobeem accept Medicare?
- Mark Sharobeem is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Mark Sharobeem's NPI active?
- Yes — Mark Sharobeem's NPI (1679915508) is active in the NPPES registry as of the last update on 2019-07-11.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.